Skip to main content

Published locations for FDA OKs Iqirvo, First-in-Class PPAR Treatment for Primary Biliary Cholangitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA OKs Iqirvo, First-in-Class PPAR Treatment for Primary Biliary Cholangitis

User login

  • Reset your password
  • /content/fda-oks-iqirvo-first-class-ppar-treatment-primary-biliary-cholangitis
  • /familypracticenews/article/269592/liver-disease/fda-oks-iqirvo-first-class-ppar-treatment-primary
  • /gihepnews/article/269592/liver-disease/fda-oks-iqirvo-first-class-ppar-treatment-primary-biliary
  • /internalmedicinenews/article/269592/liver-disease/fda-oks-iqirvo-first-class-ppar-treatment-primary
  • /internalmedicine/article/269592/liver-disease/fda-oks-iqirvo-first-class-ppar-treatment-primary
  • /familymedicine/article/269592/liver-disease/fda-oks-iqirvo-first-class-ppar-treatment-primary